NCT05716217

Brief Summary

Female patients undergoing chemotherapy for breast cancer often experience pain and discomfort when a peripheral venous catheter is inserted. This randomized, controlled trial investigates whether there is a difference in the degree of pain during PVC insertion in patients who exercise their arms, and whether exercise improves vein status. Participation involves:

  • Everyone must have had their peripheral venous catheter (PVC) inserted at least five times in the DROP-IN, which is an outpatient clinic staffed by anesthesia nurses who are specialists in applying PVCs.
  • Everyone will three times be asked to answer some questions in the DROP-IN, have their grip strength measured in both hands, and have the course of the veins in their arms clarified.
  • The training group must do arm training exercises daily for at least eight weeks (training equipment is provided)
  • Ten participants will at the end of the project period be invited to participate in a telephone interview about experiences of vein status during a cancer treatment course.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
20 days until next milestone

Study Start

First participant enrolled

February 28, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2024

Completed
Last Updated

April 19, 2024

Status Verified

April 1, 2024

Enrollment Period

1.1 years

First QC Date

January 25, 2023

Last Update Submit

April 17, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Level of pain as measure by the Numeric Rating Scale (score 1-10 where a low value defines low level of pain)

    Pain level after insertion of periphral venous catheter and at general activity measured with Numeric Rating Scale

    Measured at baseline

  • Level of pain as measure by the Numeric Rating Scale (score 1-10 where a low value defines low level of pain)

    Pain level after insertion of periphral venous catheter and at general activity measured with Numeric Rating Scale

    Measured after five weeks of training/control

  • Level of pain as measure by the Numeric Rating Scale (score 1-10 where a low value defines low level of pain)

    Pain level after insertion of periphral venous catheter and at general activity measured with Numeric Rating Scale

    Measured after eight weeks of training/control

Secondary Outcomes (3)

  • Vein status

    Measured at baseline

  • Vein status

    Measured after five weeks of training/controll

  • Vein status

    Measured after eight weeks of training/control

Study Arms (2)

Training group

EXPERIMENTAL
Other: Arm training

Normal care

NO INTERVENTION

Interventions

Daily arm training program

Training group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Planned neoadjuvant or adjuvant chemotherapy via intravenous peripheral venous cannula placed under ultrasound guidance
  • PVC insertion is performed in the DROP-IN outpatient clinic, Department of Anesthesiology, Vejle Hospital, at least four times
  • The patient has provided written and orally informed consent
  • The patient must be cognitively well preserved and able to understand information

You may not qualify if:

  • Patients who cannot read and understand Danish
  • Patients \<18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vejle Hospital

Vejle, Southern Jutland, 7100, Denmark

Location

MeSH Terms

Conditions

PainNeoplasms

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hanne I Jensen, PhD

    Vejle Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
The anaesthesia nurses inserting PVCs and registering data are blinded to the participants' study allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One group is randomly assigned to an 8-week daily arm training program. The other group receives normal care
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2023

First Posted

February 8, 2023

Study Start

February 28, 2023

Primary Completion

April 16, 2024

Study Completion

April 16, 2024

Last Updated

April 19, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations